TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/07/2025
Voltar para busca
Dado oficial do USPTO
CAEDO ONCOLOGY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
23/07/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 40, 42
Data de depósito
20/12/2021
Data de registro
25/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/07/2023
Última transação
23/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
NO
Examinador
LEE, DOUGLAS
Unidade examinadora
O20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "CAEDO ONCOLOGY" and an incomplete circle with a six pointed star inside.
Titulares e representantes
Titulares
C. A. (pessoa física)
Representantes
Susan Stabe Kutak Rock LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparations for treatment of cancer and tumours; Immunotherapeutic preparations; preparations for treatment of cancer; preparations for treatment of tumors; anti-cancer preparations; biological preparations for treatment of tumors; immunostimulatory preparations
Classe 35
Retail store services featuring pharmaceuticalsimmunotherapeuticimmunostimulatory and biological products for medical purposes; retail store services featuring pharmaceutical and biological products for treatment of cancer and products for treatment of tumors; retail store services featuring immunotherapeutic productsimmunostimulatory products and anti-cancer products
Classe 40
Treatment of materials for use in production of pharmaceuticals; custom production and custom manufacturing of pharmaceuticals; custom production and custom manufacturing of immunotherapeutic preparationspreparations for treatment of cancerpreparations for treatment of tumorsanti-cancer preparationsbiological preparations for medical purposesbiological preparations for treatment of cancerbiological preparations for treatment of tumors and immunostimulatory preparations
Classe 42
Research and development of pharmaceuticals; research and development of pharmaceutical preparations for treatment of cancerimmunotherapeutic preparationspreparations for treatment of tumorsanti-cancer preparationsbiological preparations for medical purposesbiological preparations for treatment of cancerbiological preparations for treatment of tumors and immunostimulatory preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
17/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/07/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/02/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/01/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/01/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/10/2023
FIMP
FINAL DISPOSITION PROCESSED
25/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/10/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
25/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/03/2023
RFNT
REFUSAL PROCESSED BY IB
04/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/12/2022
RFRR
REFUSAL PROCESSED BY MPU
14/12/2022
ATRV
ATTORNEY REVIEW COMPLETED
29/10/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
28/10/2022
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
28/10/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/10/2022
CNRT
NON-FINAL ACTION WRITTEN
03/10/2022
DOCK
ASSIGNED TO EXAMINER
26/09/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
23/07/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/05/2022
MAFR
APPLICATION FILING RECEIPT MAILED
15/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CAEDO ONCOLOGY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.